NCT01747486
- Conditions
- Adult Patients Who Have Relapsed or Refractory CLL (3rd Line) or SLL
- Locations
-
- Abramsonc Cancer Center of The University of Pennsylvania Philadelphia, Pennsylvania, United States
Clinical trial condition
Adult Patients Who Have Relapsed or Refractory CLL (3rd Line) or SLL
Explore clinical trials studying Adult Patients Who Have Relapsed or Refractory CLL (3rd Line) or SLL. Study availability and eligibility vary by location and protocol.
1 public trial
0 recruiting studies